- Male
- 34 Years
- 11/09/2025
My CRP is 46. Is it too high? Am I in danger? I have fever, cold and body pain for 5 days and I am taking Abphylline tablet along with Montek LC. Fever is not going away. My ESR and CRP are high. Am I safe? Please check my report.
Answered by 1 Apollo Doctors
CRP 46 is high and indicates inflammation or infection. Fever, body ache, and cold for 5 days may mean a viral or bacterial infection. You are not in immediate danger but need proper medical review.
Dr. Kamran Suggests...
Take a CBC+ESR Test or Take a C-REACTIVE PROTEIN (CRP) - QUANTITATIVE Test
Answered 11/09/2025
0
0
More C-REACTIVE PROTEIN (CRP) - QUANTITATIVE Health Queries
View allI usually feel discomfort with pain like the touch of a needle in my anus throughout the day and night. Sometimes my stomach is painful and foods are not digested easily. I feel gas in my stomach. At night I feel a burning sensation and pain because of my wound in the anal canal. I have taken many allopathic homeopathic and ayurvedic medicines but none have worked. Please suggest a minimal medicine with a powerful dose to help me recover. This is my last try otherwise I fear serious consequences?
read more![Doctor 1]()
![Doctor 2]()
Answered by Apollo Doctors
Patchy inflammation in both upper lobes as I was detected covid positive twenty days earlier. Now my report is negative but I still have some heaviness in the chest. CRP is 11.10 and IL6 is 23.58. Should I go for steroids as suggested by doctors or should I wait and manage with steaming and turmeric milk. Will I recover on my own?
read more![Doctor 1]()
![Doctor 2]()
Answered by Apollo Doctors
I am 13 weeks pregnant and had a fever. The doctor gave me a blood test, and I am sending my report. I have a low TWBC count in my blood. Is this a problem for me or my baby?
read more![Doctor 1]()
![Doctor 2]()
Answered by Apollo Doctors
Disclaimer: Answers on Apollo 247 are not intended to replace your doctor advice. Always seek help of a professional doctor in case of an medical emergency or ailment.
